Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NC9E
|
|||
| Drug Name |
SGX301
|
|||
| Indication | Cutaneous T-cell lymphoma [ICD-11: 2B01; ICD-10: C84.8; ICD-9: 202.1, 202.2] | Phase 3 | [1] | |
| Company |
Soligenix, Princeton, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.